63 results
8-K
EX-1.1
PROK
ProKidney Corp - Ordinary Shares
19 Jan 24
Entry into a Material Definitive Agreement
4:19pm
timely filing with the Commission or retention where required and legending, and each such Free Writing Prospectus, as of its issue date and at all
8-K
PROK
ProKidney Corp - Ordinary Shares
20 Nov 23
Regulation FD Disclosure
6:11am
in employee retention as a result of the Share Repurchase, (vi) the outcome of any legal proceedings that may be instituted against the Company
DEF 14A
7zu8ocm0ghhaftj18a
26 May 23
Definitive proxy
8:00am
424B3
y58j62 h2
21 Apr 23
Prospectus supplement
4:18pm
POS AM
ebzqeb1hv
17 Apr 23
Prospectus update (post-effective amendment)
5:01pm
8-K
EX-10.5
qam0e38ou7z4mw
15 Jul 22
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq
5:24pm
DEFA14A
1karw5qstpmgoyb30fky
8 Jul 22
Additional proxy soliciting materials
9:17pm
8-K
xmb7 8oif7cb3t934l7
8 Jul 22
Social Capital Suvretta Holdings Corp. III Announces Reconvened Extraordinary General
9:09pm
8-K
EX-99.1
3j4x zpugrmirv7
8 Jul 22
Social Capital Suvretta Holdings Corp. III Announces Reconvened Extraordinary General
9:09pm